Theralase Technologies Inc. Cash Flow Conversion Efficiency

Latest as of June 2026: -0.180x

Theralase Technologies Inc. cash flow conversion efficiency. Based on the latest financial reports, Theralase Technologies Inc. (TLT) has a cash flow conversion efficiency ratio of -0.180x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.23 Million ≈ $-889.90K USD) by net assets (CA$6.84 Million ≈ $4.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Theralase Technologies Inc. (2001–2025)

Cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2025. This chart illustrates how Theralase Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View TLT stock price and chart for real-time trading data and today's change.

Theralase Technologies Inc. Cash Flow Conversion Ratio Explained

Theralase Technologies Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Theralase Technologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theralase Technologies Inc. ranked by their cash flow conversion efficiency. Also see Theralase Technologies Inc. market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
De Nora India Limited NSE:DENORA	0.179x
Stalprofil S.A. WAR:STF	0.114x
Namyang Dairy Products Co Ltd Peffered Series 1 KO:003925	0.003x
Poongwon Precision Co. Ltd. KQ:371950	-0.270x
Namib Minerals Ordinary Shares NASDAQ:NAMM	-0.351x
HS Valve Co. Ltd KQ:039610	0.001x
Feerum S.A. WAR:FEE	0.073x
Histeel KO:071090	-0.103x

Annual Cash Flow Conversion Efficiency for Theralase Technologies Inc. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2025. Review cash generation quality of Theralase Technologies Inc. to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$1.78 Million ≈ $1.29 Million	CA$-3.29 Million ≈ $-2.38 Million	-1.848x	-14.88%
2024-12-31	CA$2.07 Million ≈ $1.50 Million	CA$-3.33 Million ≈ $-2.41 Million	-1.609x	+24.73%
2023-12-31	CA$1.91 Million ≈ $1.38 Million	CA$-4.07 Million ≈ $-2.95 Million	-2.137x	-28.78%
2022-12-31	CA$3.09 Million ≈ $2.24 Million	CA$-5.13 Million ≈ $-3.71 Million	-1.660x	-108.79%
2021-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.03 Million ≈ $-2.92 Million	-0.795x	-63.83%
2020-12-31	CA$9.16 Million ≈ $6.63 Million	CA$-4.45 Million ≈ $-3.22 Million	-0.485x	-2.38%
2019-12-31	CA$13.86 Million ≈ $10.02 Million	CA$-6.57 Million ≈ $-4.75 Million	-0.474x	+61.07%
2018-12-31	CA$998.64K ≈ $722.40K	CA$-1.22 Million ≈ $-879.39K	-1.217x	+41.54%
2017-12-31	CA$2.05 Million ≈ $1.48 Million	CA$-4.26 Million ≈ $-3.08 Million	-2.082x	-142.84%
2016-12-31	CA$5.69 Million ≈ $4.12 Million	CA$-4.88 Million ≈ $-3.53 Million	-0.858x	-7.39%
2015-12-31	CA$6.32 Million ≈ $4.57 Million	CA$-5.04 Million ≈ $-3.65 Million	-0.799x	+27.19%
2014-12-31	CA$3.31 Million ≈ $2.39 Million	CA$-3.63 Million ≈ $-2.62 Million	-1.097x	-111.05%
2013-12-31	CA$1.76 Million ≈ $1.28 Million	CA$-916.67K ≈ $-663.11K	-0.520x	-105.54%
2012-12-31	CA$-64.73K ≈ $-46.82K	CA$-606.72K ≈ $-438.89K	9.373x	+405.21%
2011-12-31	CA$455.16K ≈ $329.25K	CA$-1.40 Million ≈ $-1.01 Million	-3.071x	-663.82%
2010-12-31	CA$2.53 Million ≈ $1.83 Million	CA$-1.02 Million ≈ $-735.94K	-0.402x	-3323.44%
2009-12-31	CA$3.49 Million ≈ $2.52 Million	CA$-40.95K ≈ $-29.62K	-0.012x	+92.02%
2008-12-31	CA$2.39 Million ≈ $1.73 Million	CA$-351.19K ≈ $-254.05K	-0.147x	-41.17%
2007-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-351.49K ≈ $-254.26K	-0.104x	-1262.74%
2006-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-25.78K ≈ $-18.65K	-0.008x	-130.39%
2005-12-31	CA$3.39 Million ≈ $2.45 Million	CA$85.33K ≈ $61.73K	0.025x	+130.40%
2004-12-31	CA$1.05 Million ≈ $762.12K	CA$-87.23K ≈ $-63.10K	-0.083x	+82.82%
2003-12-31	CA$399.21K ≈ $288.78K	CA$-192.39K ≈ $-139.17K	-0.482x	+13.24%
2002-12-31	CA$87.35K ≈ $63.19K	CA$-48.52K ≈ $-35.10K	-0.555x	+7.87%
2001-12-31	CA$137.03K ≈ $99.13K	CA$-82.62K ≈ $-59.76K	-0.603x	--

About Theralase Technologies Inc.

V:TLT Canada Medical Devices

Market Cap

$40.43 Million

CA$55.89 Million CAD

Market Cap Rank

#22479 Global

#791 in Canada

Share Price

CA$0.18

Change (1 day)

-7.69%

52-Week Range

CA$0.15 - CA$0.39

All Time High

CA$0.58